Aqr Capital Management LLC V Tv Therapeutics Inc. Transaction History

Aqr Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$1.53 - $2.22 $80,549 - $116,876	-52,647 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.27 - $3.44 $48,650 - $73,726	21,432 Added 68.66%	52,647 $120,000
Q1 2021 May 17, 2021	BUY	$1.97 - $2.89 $61,493 - $90,211	31,215 New	31,215 $88,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.43B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.